Bias-Free Artificial Intelligence in Health

4 min 35 sec April 23, 2026 (Edited)

Written by

David Yates

Partner, Head of Digital & Data

d.yates@tamimi.com View LinkedIn Profile

The Pan American Health Organization (PAHO) recently has published a guideline entitled “Bias-Free Artificial Intelligence in Health: Dos and Don’ts for Developing and Implementing Algorithms,” that provides a practical framework for governments, health authorities, and partners to develop and deploy AI systems in public health that are responsible, accurate, and free from harmful bias.  We have discussed the key points below (so you don’t have to wade through the detail).

Artificial intelligence is transforming public health by strengthening disease surveillance, improving diagnosis, optimizing resource allocation, and guiding preventive action. However, algorithms are not neutral — they inherit the strengths and weaknesses of the data, assumptions, and systems that create them. When trained on incomplete or unrepresentative data, AI models can produce inaccurate predictions, reinforce existing disparities, or systematically underperform for certain population groups. Addressing bias is therefore framed not only as harm prevention but as essential for unlocking AI’s full potential and improving overall system performance.

The guideline targets a broad audience including ministries of health, regulatory authorities, public health institutes, universities, international organizations, private sector actors, and civil society. Its objectives include providing a structured approach for identifying and addressing factors that reduce AI accuracy, strengthening national capacities for data quality assessment and algorithm validation, supporting policy development, and highlighting how bias-free AI leads to earlier detection, more precise interventions, and more efficient resource use.

Bias-free AI is a strategic policy priority, not merely a technical correction. For ministries of health, integrating AI into decision-making brings two priorities: ensuring trustworthy automation and demonstrating measurable results. Algorithms that perform inconsistently or lack transparency can reduce institutional confidence, whereas validated and explainable systems strengthen credibility.

A bias-free framework improves governance and accountability by making AI decisions traceable and data sources well-documented, enabling ministries to audit results, justify interventions, and adapt programs based on evidence. Countries that institutionalize bias-free standards gain predictable performance, stronger interoperability, and more consistent outcomes. AI must be transparent, accountable, and aligned with the fundamental values of public health.

Bias may enter an AI system at any phase of its life cycle, from problem formulation to data collection, model development, validation, deployment, and monitoring. There are several types of bias:

– Data representation bias occurs when training datasets do not reflect the target population in terms of gender, ethnicity, geography, or socioeconomic diversity.

– Historical and contextual bias arises when training data reflect past access patterns, service delivery inequities, or unbalanced system structures.

– Measurement and annotation bias stems from the use of proxies or indirect measures and subjective or inconsistent labeling of training data.

– Aggregation and algorithmic bias occurs when data or modeling choices collapse meaningful subpopulation differences, or when optimization criteria focus only on global accuracy.

– Deployment and context bias materializes after deployment due to changes in population, health-system settings, or data collection processes (often called “data drift”).

The guideline identifies four foundational pillars. First, strengthening data quality and representativeness: governments should adopt systematic data-quality standards requiring metadata documentation, consistent variable definitions, and disaggregation by sex, age, geography, and other relevant dimensions. Second, promoting transparency and explainability: developers must maintain open documentation and use explainable AI techniques such as model cards, interpretable architectures, and feature-importance visualizations. Third, ensuring participation and inclusion: multidisciplinary teams comprising data scientists, clinicians, epidemiologists, and community representatives should be involved in design and deployment. Fourth, embedding human oversight and accountability: AI applications must remain under human supervision, with clear lines of accountability defining who is responsible for model performance, monitoring, and corrective actions.

The guideline recommends several concrete technical strategies: collecting and curating diverse, high-quality training data; applying fairness-aware data preprocessing techniques to address class imbalance; implementing fairness constraints directly into model training and optimization; incorporating transparency, explainability, and interpretability features; conducting rigorous disaggregated validation and fairness auditing across subgroups before and after deployment; and integrating accountability and governance mechanisms such as algorithm review committees and model-card requirements throughout the AI life cycle.

The guideline offers detailed recommendations across six domains:

1. Data collection and curation — Establish national data-governance frameworks, ensure datasets reflect population diversity, integrate data from multiple health levels, and mitigate historical bias through preliminary reviews.
2. Model development and training — Require fairness-aware algorithms, mandate transparent documentation, embed human oversight checkpoints, mandate explainability and interpretability, and demand algorithmic traceability.
3. Validation and evaluation — Make external and independent validation mandatory before deployment, require disaggregated and intersectional performance reporting, maintain a national registry of validated AI systems, and require prospective and real-world validation.
4. Deployment and monitoring — Implement continuous monitoring pipelines, integrate AI oversight into national quality-assurance systems, provide ongoing training for professionals, institutionalize recalibration cycles, and establish clear protocols for model decommissioning.
5. Governance and accountability — Create national AI oversight committees, define transparent accountability lines, publish documentation of approved systems, integrate privacy-by-design measures, ensure patient and community representation, establish clear accountability frameworks, require model cards in procurement, and establish formal channels for reporting algorithmic incidents.
6. Regional cooperation and capacity development — Participate in regional mechanisms for sharing best practices, promote open data principles and interoperable standards, develop structured training programs, and build sustainable local expertise through university curricula and professional career pathways.

The document provides tailored guidance for five stakeholder groups: policymakers (require representative data, mandate external validation, establish oversight committees); health workers (use AI as a support tool, maintain professional judgment, obtain informed consent); patients (ask about AI use, request plain-language explanations, confirm human review); developers (codesign with clinicians and communities, build in explainability, provide full documentation); and hospital directors (understand systems before implementation, start with pilots, keep human judgment central).